Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Operating Expenses: 2018-2024

Historic Operating Expenses for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $689.5 million.

  • Revolution Medicines' Operating Expenses rose 79.42% to $315.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 58.59%. This contributed to the annual value of $689.5 million for FY2024, which is 38.25% up from last year.
  • As of FY2024, Revolution Medicines' Operating Expenses stood at $689.5 million, which was up 38.25% from $498.8 million recorded in FY2023.
  • Revolution Medicines' 5-year Operating Expenses high stood at $689.5 million for FY2024, and its period low was $153.7 million during FY2020.
  • For the 3-year period, Revolution Medicines' Operating Expenses averaged around $494.0 million, with its median value being $498.8 million (2023).
  • Data for Revolution Medicines' Operating Expenses shows a peak YoY surged of 69.84% (in 2023) over the last 5 years.
  • Revolution Medicines' Operating Expenses (Yearly) stood at $153.7 million in 2020, then spiked by 41.46% to $217.4 million in 2021, then skyrocketed by 35.08% to $293.7 million in 2022, then spiked by 69.84% to $498.8 million in 2023, then skyrocketed by 38.25% to $689.5 million in 2024.